# The PfK13 G533S mutation confers artemisinin partial resistance in multiple genetic backgrounds of Plasmodium falciparum

**Authors:** Faiza Amber Siddiqui, Aongruk Chim-Ong, Chenqi Wang, Jun Miao, Liwang Cui

PMC · DOI: 10.1128/aac.00162-25 · Antimicrobial Agents and Chemotherapy · 2025-05-27

## TL;DR

The PfK13 G533S mutation increases resistance to artemisinin in malaria parasites across different genetic backgrounds.

## Contribution

The PfK13 G533S mutation is shown to confer artemisinin resistance in multiple parasite strains with minimal fitness cost.

## Key findings

- The PfK13 G533S mutation increased ring-stage survival rates by 12%–23% across four parasite strains.
- The PfK13 G533S mutation is associated with slower parasite clearance and higher day-3 positivity rates in field isolates.
- The PfK13 G533A mutation did not increase ring-stage survival rates in engineered strains.

## Abstract

Mutations in the Plasmodium falciparum Kelch 13 (PfK13) protein are the key determinant of artemisinin partial resistance. While more than 200 PfK13 mutations have been identified in global parasite populations, only 13 have been validated to confer in vivo or in vitro artemisinin partial resistance. In the western Greater Mekong Subregion, the prevalence of the PfK13 G533S mutation has significantly increased in recent years. Field isolates carrying the PfK13 G533S mutation showed slower parasite clearance and higher day-3 positivity rates after artemisinin treatment, while culture-adapted isolates displayed significantly elevated ring-stage survival rates. Here, the PfK13 G533S mutation was introduced using CRISPR/Cas9 into four parasite strains: Dd2, 3D7, GB4, and F09N25 (a recent culture-adapted field isolate from the China-Myanmar border area). Across all four genetic backgrounds, the PfK13 G533S mutation conferred ring-stage survival rates of 12%–23% with a minimal fitness cost, explaining its rising prevalence in the region. In contrast, the PfK13 G533A mutation, sporadically detected in world P. falciparum populations, did not increase ring-stage survival rates when engineered into the 3D7 and Dd2 strains. These findings validate the PfK13 G533S mutation as a critical marker for artemisinin resistance surveillance and underscore the importance of monitoring its spread.

## Linked entities

- **Genes:** PFK1_3 (6-phosphofructokinase, alpha subunit) [NCBI Gene 19249209]
- **Chemicals:** artemisinin (PubChem CID 68827)
- **Diseases:** malaria (MONDO:0005136)
- **Species:** Plasmodium falciparum (taxon 5833)

## Full-text entities

- **Chemicals:** artemisinin (MESH:C031327)
- **Species:** Plasmodium falciparum (malaria parasite P. falciparum, species) [taxon 5833]
- **Mutations:** G533S, G533A
- **Cell lines:** Dd2 — Cricetulus griseus (Chinese hamster), Transformed cell line (CVCL_YD16), 3D7 — Mus musculus (Mouse), Hybridoma (CVCL_KS87)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12217484/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12217484/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12217484/full.md

---
Source: https://tomesphere.com/paper/PMC12217484